To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation? [PDF]
Ollier L+7 more
europepmc +1 more source
Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B. [PDF]
Jiang B+13 more
europepmc +1 more source
Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss. [PDF]
Gao N+9 more
europepmc +1 more source
Sero-prevalence of hepatitis B virus and associated risk factors among pregnant women attending Demartino hospital, Mogadishu, Somalia. [PDF]
Mohamud OM+5 more
europepmc +1 more source
An immune-based predictive model for HBV clearance: validation in multicenter cohorts and mechanistic insights from in vivo studies. [PDF]
Zhang R+8 more
europepmc +1 more source
Double reflex testing improves the efficacy and cost effectiveness of hepatitis delta diagnosis in southern Spain. [PDF]
Fuentes A+38 more
europepmc +1 more source
Hepatitis B surface antigen hijacks TANK-binding kinase 1 to suppress type I interferon and induce early autophagy. [PDF]
Luo C+11 more
europepmc +1 more source
Investigation of Hepatitis B Virus (HBsAg, Anti-HBs) and Anti-Hepatitis C Virus Serology in Erzurum Region: 2015-2023. [PDF]
Uçar M+3 more
europepmc +1 more source
Health economic evaluation of newborn hepatitis B immunization prevention strategies in Ningbo: a Markov modeling study. [PDF]
Feng W+7 more
europepmc +1 more source